These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 22291913)

  • 61. Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.
    Rong L; Perelson AS
    PLoS Comput Biol; 2009 Oct; 5(10):e1000533. PubMed ID: 19834532
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
    Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
    J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The role of integration and clonal expansion in HIV infection: live long and prosper.
    Anderson EM; Maldarelli F
    Retrovirology; 2018 Oct; 15(1):71. PubMed ID: 30352600
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
    Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Extensive proteomic and transcriptomic changes quench the TCR/CD3 activation signal of latently HIV-1 infected T cells.
    Carlin E; Greer B; Lowman K; Duverger A; Wagner F; Moylan D; Dalecki A; Samuel S; Perez M; Sabbaj S; Kutsch O
    PLoS Pathog; 2021 Jan; 17(1):e1008748. PubMed ID: 33465149
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Transcriptome profiles of latently- and reactivated HIV-1 infected primary CD4
    Inderbitzin A; Loosli T; Opitz L; Rusert P; Metzner KJ
    Front Immunol; 2022; 13():915805. PubMed ID: 36090997
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells.
    Bosque A; Famiglietti M; Weyrich AS; Goulston C; Planelles V
    PLoS Pathog; 2011 Oct; 7(10):e1002288. PubMed ID: 21998586
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Improved assays to measure and characterize the inducible HIV reservoir.
    Massanella M; Yek C; Lada SM; Nakazawa M; Shefa N; Huang K; Richman DD
    EBioMedicine; 2018 Oct; 36():113-121. PubMed ID: 30316868
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Host T Cell Dedifferentiation Effects Drive HIV-1 Latency Stability.
    Dalecki AG; Greer BD; Duverger A; Strange EL; Carlin E; Wagner F; Shi B; Lowman KE; Perez M; Tidwell C; Kaczmarek Michaels K; Giattina S; Bossmann SH; Henderson AJ; Hu H; Kutsch O
    J Virol; 2022 Mar; 96(5):e0197421. PubMed ID: 35019721
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence.
    Murray AJ; Kwon KJ; Farber DL; Siliciano RF
    J Immunol; 2016 Jul; 197(2):407-17. PubMed ID: 27382129
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Single-cell RNA sequencing reveals common and unique gene expression profiles in primary CD4+ T cells latently infected with HIV under different conditions.
    Zhang X; Qazi AA; Deshmukh S; Lobato Ventura R; Mukim A; Beliakova-Bethell N
    Front Cell Infect Microbiol; 2023; 13():1286168. PubMed ID: 38156317
    [TBL] [Abstract][Full Text] [Related]  

  • 72. HIV-1 Genomes Are Enriched in Memory CD4
    Morcilla V; Bacchus-Souffan C; Fisher K; Horsburgh BA; Hiener B; Wang XQ; Schlub TE; Fitch M; Hoh R; Hecht FM; Martin JN; Deeks SG; Hellerstein MK; McCune JM; Hunt PW; Palmer S
    mBio; 2021 Oct; 12(5):e0244721. PubMed ID: 34544282
    [TBL] [Abstract][Full Text] [Related]  

  • 73. HIV-1 integration landscape during latent and active infection.
    Cohn LB; Silva IT; Oliveira TY; Rosales RA; Parrish EH; Learn GH; Hahn BH; Czartoski JL; McElrath MJ; Lehmann C; Klein F; Caskey M; Walker BD; Siliciano JD; Siliciano RF; Jankovic M; Nussenzweig MC
    Cell; 2015 Jan; 160(3):420-32. PubMed ID: 25635456
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway.
    van Montfort T; van der Sluis R; Darcis G; Beaty D; Groen K; Pasternak AO; Pollakis G; Vink M; Westerhout EM; Hamdi M; Bakker M; van der Putten B; Jurriaans S; Prins JH; Jeeninga R; Thomas AAM; Speijer D; Berkhout B
    EBioMedicine; 2019 Apr; 42():97-108. PubMed ID: 30824386
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 Infection.
    Seu L; Sabbaj S; Duverger A; Wagner F; Anderson JC; Davies E; Wolschendorf F; Willey CD; Saag MS; Goepfert P; Kutsch O
    J Virol; 2015 Jul; 89(13):6656-72. PubMed ID: 25878110
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane.
    Wang Z; Gurule EE; Brennan TP; Gerold JM; Kwon KJ; Hosmane NN; Kumar MR; Beg SA; Capoferri AA; Ray SC; Ho YC; Hill AL; Siliciano JD; Siliciano RF
    Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2575-E2584. PubMed ID: 29483265
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.
    Chun TW; Finzi D; Margolick J; Chadwick K; Schwartz D; Siliciano RF
    Nat Med; 1995 Dec; 1(12):1284-90. PubMed ID: 7489410
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.
    White CH; Moesker B; Beliakova-Bethell N; Martins LJ; Spina CA; Margolis DM; Richman DD; Planelles V; Bosque A; Woelk CH
    PLoS Pathog; 2016 Nov; 12(11):e1006026. PubMed ID: 27898737
    [TBL] [Abstract][Full Text] [Related]  

  • 79. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
    Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
    mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Astrocytes sustain long-term productive HIV-1 infection without establishment of reactivable viral latency.
    Barat C; Proust A; Deshiere A; Leboeuf M; Drouin J; Tremblay MJ
    Glia; 2018 Jul; 66(7):1363-1381. PubMed ID: 29464785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.